David G. Mcleod
Center for Prostate Disease Research/Urology Service
Uniformed Services University
Walter Reed Army Medical Center
Bethesda
USA
Name/email consistency: high
- Editorial comment on: new treatment approaches for prostate cancer based on peptide analogues. McLeod, D.G. Eur. Urol. (2008)
- Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer. McLeod, D.G., Iversen, P., See, W.A., Morris, T., Armstrong, J., Wirth, M.P. BJU Int. (2006)
- The bicalutamide 150 mg early prostate cancer program: findings of the North American trial at 7.7-year median followup. McLeod, D.G., See, W.A., Klimberg, I., Gleason, D., Chodak, G., Montie, J., Bernstein, G., Morris, C., Armstrong, J. J. Urol. (2006)
- Hormonal therapy: historical perspective to future directions. Mcleod, D.G. Urology (2003)